# Zumiez Inc: financial statements, quarterly ZUMZ · Nasdaq · CIK 1318008 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Feb 3 Pages: [Overview](/companies/zumz.md) · [Financials](/companies/zumz/financials.md) · [Filings](/companies/zumz/filings.md) · [Insiders](/companies/zumz/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/zumz/financials.md?period=annual). ## Income statement | Line item | Unit | Q3 FY2023 (2023-10-28) | Q4 FY2023 (2024-02-03) | Q1 FY2024 (2024-05-04) | Q2 FY2024 (2024-08-03) | Q3 FY2024 (2024-11-02) | Q4 FY2024 (2025-02-01) | Q1 FY2025 (2025-05-03) | Q2 FY2025 (2025-08-02) | Q3 FY2025 (2025-11-01) | Q4 FY2025 (2026-01-31) | Q1 FY2026 (2026-05-02) | Q2 FY2026 (2026-08-01) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [216](/filings/0000950170-24-133660.md) | [282 d](/filings/0001193125-26-104063.md) | [177](/filings/0000950170-25-082292.md) | [210](/filings/0001318008-25-000005.md) | [222](/filings/0001193125-25-308054.md) | [279 d](/filings/0001193125-26-104063.md) | [184](/filings/0001193125-26-257341.md) | [214](/filings/0001193125-26-387835.md) | [239](/filings/0001193125-25-308054.md) | [291 d](/filings/0001193125-26-104063.md) | [193](/filings/0001193125-26-257341.md) | [209](/filings/0001193125-26-387835.md) | | Cost of revenue | $m | [143](/filings/0000950170-24-133660.md) | [185 d](/filings/0001193125-26-104063.md) | [125](/filings/0000950170-25-082292.md) | [138](/filings/0001318008-25-000005.md) | [144](/filings/0001193125-25-308054.md) | [178 d](/filings/0001193125-26-104063.md) | [129](/filings/0001193125-26-257341.md) | [138](/filings/0001193125-26-387835.md) | [149](/filings/0001193125-25-308054.md) | [180 d](/filings/0001193125-26-104063.md) | [132](/filings/0001193125-26-257341.md) | [135](/filings/0001193125-26-387835.md) | | Gross profit | $m | [73.2](/filings/0000950170-24-133660.md) | [96.7 d](/filings/0001193125-26-104063.md) | [51.9](/filings/0000950170-25-082292.md) | [71.8](/filings/0001318008-25-000005.md) | [78.3](/filings/0001193125-25-308054.md) | [101 d](/filings/0001193125-26-104063.md) | [55.3](/filings/0001193125-26-257341.md) | [76.0](/filings/0001193125-26-387835.md) | [89.8](/filings/0001193125-25-308054.md) | [111 d](/filings/0001193125-26-104063.md) | [61.3](/filings/0001193125-26-257341.md) | [73.9](/filings/0001193125-26-387835.md) | | Selling, general and administrative | $m | [73.4](/filings/0000950170-24-133660.md) | [129 d](/filings/0001193125-26-104063.md) | [72.1](/filings/0000950170-25-082292.md) | [72.2](/filings/0001318008-25-000005.md) | [75.9](/filings/0001193125-25-308054.md) | [80.9 d](/filings/0001193125-26-104063.md) | [75.2](/filings/0001193125-26-257341.md) | [75.9](/filings/0001193125-26-387835.md) | [78.0](/filings/0001193125-25-308054.md) | [86.4 d](/filings/0001193125-26-104063.md) | [76.5](/filings/0001193125-26-257341.md) | [75.2](/filings/0001193125-26-387835.md) | | Operating income | $m | [(0.2)](/filings/0000950170-24-133660.md) | [(32.8) d](/filings/0001193125-26-104063.md) | [(20.2)](/filings/0000950170-25-082292.md) | [(0.4)](/filings/0001318008-25-000005.md) | [2.4](/filings/0001193125-25-308054.md) | [20.1 d](/filings/0001193125-26-104063.md) | [(19.9)](/filings/0001193125-26-257341.md) | [0.1](/filings/0001193125-26-387835.md) | [11.8](/filings/0001193125-25-308054.md) | [25.0 d](/filings/0001193125-26-104063.md) | [(15.2)](/filings/0001193125-26-257341.md) | [(1.3)](/filings/0001193125-26-387835.md) | | Income tax | $m | [2.0](/filings/0000950170-24-133660.md) | [2.2 d](/filings/0001193125-26-104063.md) | [(2.8)](/filings/0000950170-25-082292.md) | [1.4](/filings/0001318008-25-000005.md) | [2.0](/filings/0001193125-25-308054.md) | [5.2 d](/filings/0001193125-26-104063.md) | [(1.4)](/filings/0001193125-26-257341.md) | [1.9](/filings/0001193125-26-387835.md) | [3.2](/filings/0001193125-25-308054.md) | [7.0 d](/filings/0001193125-26-104063.md) | [(1.2)](/filings/0001193125-26-257341.md) | [1.3](/filings/0001193125-26-387835.md) | | Net income | $m | [(2.2)](/filings/0000950170-24-133660.md) | [(33.5) d](/filings/0001193125-26-104063.md) | [(16.8)](/filings/0000950170-25-082292.md) | [(0.8)](/filings/0001318008-25-000005.md) | [1.2](/filings/0001193125-25-308054.md) | [14.8 d](/filings/0001193125-26-104063.md) | [(14.3)](/filings/0001193125-26-257341.md) | [(1.0)](/filings/0001193125-26-387835.md) | [9.2](/filings/0001193125-25-308054.md) | [19.6 d](/filings/0001193125-26-104063.md) | [(13.3)](/filings/0001193125-26-257341.md) | [(2.7)](/filings/0001193125-26-387835.md) | | Diluted EPS | $ per share | [(0.12)](/filings/0000950170-24-133660.md) | not reported | [(0.86)](/filings/0000950170-25-082292.md) | [(0.04)](/filings/0001318008-25-000005.md) | [0.06](/filings/0001193125-25-308054.md) | not reported | [(0.79)](/filings/0001193125-26-257341.md) | [(0.06)](/filings/0001193125-26-387835.md) | [0.55](/filings/0001193125-25-308054.md) | not reported | [(0.82)](/filings/0001193125-26-257341.md) | [(0.17)](/filings/0001193125-26-387835.md) | | Basic EPS | $ per share | [(0.12)](/filings/0000950170-24-133660.md) | not reported | [(0.86)](/filings/0000950170-25-082292.md) | [(0.04)](/filings/0001318008-25-000005.md) | [0.06](/filings/0001193125-25-308054.md) | not reported | [(0.79)](/filings/0001193125-26-257341.md) | [(0.06)](/filings/0001193125-26-387835.md) | [0.57](/filings/0001193125-25-308054.md) | not reported | [(0.82)](/filings/0001193125-26-257341.md) | [(0.17)](/filings/0001193125-26-387835.md) | - Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax - Cost of revenue: us-gaap:CostOfGoodsAndServicesSold - Gross profit: us-gaap:GrossProfit - Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense - Operating income: us-gaap:OperatingIncomeLoss - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | Q3 FY2023 (2023-10-28) | FY2023 (2024-02-03) | Q1 FY2024 (2024-05-04) | Q2 FY2024 (2024-08-03) | Q3 FY2024 (2024-11-02) | FY2024 (2025-02-01) | Q1 FY2025 (2025-05-03) | Q2 FY2025 (2025-08-02) | Q3 FY2025 (2025-11-01) | FY2025 (2026-01-31) | Q1 FY2026 (2026-05-02) | Q2 FY2026 (2026-08-01) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | [49.0](/filings/0000950170-23-067730.md) | [88.9](/filings/0001193125-26-104063.md) | [74.9](/filings/0000950170-24-071264.md) | [65.8](/filings/0000950170-24-103958.md) | [48.5](/filings/0000950170-24-133660.md) | [113](/filings/0001193125-26-104063.md) | [62.5](/filings/0000950170-25-082292.md) | [78.8](/filings/0001318008-25-000005.md) | [80.1](/filings/0001193125-25-308054.md) | [128](/filings/0001193125-26-387835.md) | [66.9](/filings/0001193125-26-257341.md) | [50.3](/filings/0001193125-26-387835.md) | | Current assets | $m | [346](/filings/0000950170-23-067730.md) | [327](/filings/0000950170-25-038692.md) | [321](/filings/0000950170-24-071264.md) | [327](/filings/0000950170-24-103958.md) | [318](/filings/0000950170-24-133660.md) | [322](/filings/0001193125-26-104063.md) | [281](/filings/0000950170-25-082292.md) | [301](/filings/0001318008-25-000005.md) | [315](/filings/0001193125-25-308054.md) | [336](/filings/0001193125-26-387835.md) | [307](/filings/0001193125-26-257341.md) | [296](/filings/0001193125-26-387835.md) | | Total assets | $m | [743](/filings/0000950170-23-067730.md) | [664](/filings/0000950170-25-038692.md) | [657](/filings/0000950170-24-071264.md) | [670](/filings/0000950170-24-103958.md) | [646](/filings/0000950170-24-133660.md) | [635](/filings/0001193125-26-104063.md) | [599](/filings/0000950170-25-082292.md) | [623](/filings/0001318008-25-000005.md) | [633](/filings/0001193125-25-308054.md) | [644](/filings/0001193125-26-387835.md) | [619](/filings/0001193125-26-257341.md) | [627](/filings/0001193125-26-387835.md) | | Current liabilities | $m | [182](/filings/0000950170-23-067730.md) | [144](/filings/0000950170-25-038692.md) | [157](/filings/0000950170-24-071264.md) | [181](/filings/0000950170-24-103958.md) | [170](/filings/0000950170-24-133660.md) | [156](/filings/0001193125-26-104063.md) | [147](/filings/0000950170-25-082292.md) | [171](/filings/0001318008-25-000005.md) | [173](/filings/0001193125-25-308054.md) | [168](/filings/0001193125-26-387835.md) | [157](/filings/0001193125-26-257341.md) | [173](/filings/0001193125-26-387835.md) | | Total liabilities | $m | [364](/filings/0000950170-23-067730.md) | [311](/filings/0000950170-25-038692.md) | [319](/filings/0000950170-24-071264.md) | [350](/filings/0000950170-24-103958.md) | [329](/filings/0000950170-24-133660.md) | [306](/filings/0001193125-26-104063.md) | [301](/filings/0000950170-25-082292.md) | [331](/filings/0001318008-25-000005.md) | [335](/filings/0001193125-25-308054.md) | [320](/filings/0001193125-26-387835.md) | [313](/filings/0001193125-26-257341.md) | [348](/filings/0001193125-26-387835.md) | | Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Shareholders' equity | $m | [379](/filings/0000950170-24-133660.md) | [353](/filings/0001193125-26-104063.md) | [337](/filings/0001318008-25-000005.md) | [320](/filings/0001193125-25-308054.md) | [317](/filings/0001193125-25-308054.md) | [329](/filings/0001193125-26-387835.md) | [298](/filings/0001193125-26-387835.md) | [292](/filings/0001193125-26-387835.md) | [299](/filings/0001193125-25-308054.md) | [324](/filings/0001193125-26-387835.md) | [306](/filings/0001193125-26-387835.md) | [279](/filings/0001193125-26-387835.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Long-term debt: not reported - Current portion of debt: not reported - Short-term borrowings: not reported - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q3 FY2023 (2023-10-28) | Q4 FY2023 (2024-02-03) | Q1 FY2024 (2024-05-04) | Q2 FY2024 (2024-08-03) | Q3 FY2024 (2024-11-02) | Q4 FY2024 (2025-02-01) | Q1 FY2025 (2025-05-03) | Q2 FY2025 (2025-08-02) | Q3 FY2025 (2025-11-01) | Q4 FY2025 (2026-01-31) | Q1 FY2026 (2026-05-02) | Q2 FY2026 (2026-08-01) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [1.3 d](/filings/0000950170-24-133660.md) | [37.7 d](/filings/0001193125-26-104063.md) | [(18.6)](/filings/0000950170-25-082292.md) | [3.2 d](/filings/0001318008-25-000005.md) | [(18.6) d](/filings/0001193125-25-308054.md) | [54.7 d](/filings/0001193125-26-104063.md) | [(22.1)](/filings/0001193125-26-257341.md) | [12.6 d](/filings/0001193125-26-387835.md) | [5.3 d](/filings/0001193125-25-308054.md) | [57.7 d](/filings/0001193125-26-104063.md) | [(28.1)](/filings/0001193125-26-257341.md) | [0.8 d](/filings/0001193125-26-387835.md) | | Capital expenditure | $m | [4.3 d](/filings/0000950170-24-133660.md) | [4.1 d](/filings/0001193125-26-104063.md) | [2.5](/filings/0000950170-25-082292.md) | [3.7 d](/filings/0001318008-25-000005.md) | [3.7 d](/filings/0001193125-25-308054.md) | [5.0 d](/filings/0001193125-26-104063.md) | [2.2](/filings/0001193125-26-257341.md) | [3.1 d](/filings/0001193125-26-387835.md) | [2.2 d](/filings/0001193125-25-308054.md) | [3.5 d](/filings/0001193125-26-104063.md) | [1.7](/filings/0001193125-26-257341.md) | [3.2 d](/filings/0001193125-26-387835.md) | | Share repurchases | $m | [0.0 d](/filings/0000950170-23-067730.md) | not reported | not reported | not reported | [5.6 d](/filings/0001193125-25-308054.md) | [0.0 d](/filings/0001193125-26-104063.md) | [25.2](/filings/0001193125-26-257341.md) | [7.5 d](/filings/0001193125-26-387835.md) | [5.6 d](/filings/0001193125-25-308054.md) | [0.0 d](/filings/0001193125-26-104063.md) | [6.0](/filings/0001193125-26-257341.md) | [23.0 d](/filings/0001193125-26-387835.md) | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment - Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock ## Shares | Line item | Unit | Q3 FY2022 (2022-10-29) | Q1 FY2023 (2023-04-29) | Q2 FY2023 (2023-07-29) | Q3 FY2023 (2023-10-28) | Q1 FY2024 (2024-05-04) | Q2 FY2024 (2024-08-03) | Q3 FY2024 (2024-11-02) | Q1 FY2025 (2025-05-03) | Q2 FY2025 (2025-08-02) | Q3 FY2025 (2025-11-01) | Q1 FY2026 (2026-05-02) | Q2 FY2026 (2026-08-01) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [19.2](/filings/0000950170-23-067730.md) | [19.2](/filings/0000950170-24-071264.md) | [19.3](/filings/0000950170-24-103958.md) | [19.3](/filings/0000950170-24-133660.md) | [19.5](/filings/0000950170-25-082292.md) | [19.3](/filings/0001318008-25-000005.md) | [18.9](/filings/0001193125-25-308054.md) | [18.1](/filings/0001193125-26-257341.md) | [16.7](/filings/0001193125-26-387835.md) | [16.7](/filings/0001193125-25-308054.md) | [16.2](/filings/0001193125-26-257341.md) | [15.7](/filings/0001193125-26-387835.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Shares outstanding: 15,330,613 at 2026-08-29, from the cover of the [10-Q filed 2026-09-10](/filings/0001193125-26-387835.md) (dei:EntityCommonStockSharesOutstanding). Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:36 ET. No prices; not investment advice.